IP Library › Granted Patent US 9,976,178
Granted Patent B2
US 9,976,178 · App. 14/970,818 · Granted May 22, 2018

Polymerase compositions and methods of making and using same

Inventors: Daniel Mazur (San Diego, CA); Eileen Tozer (San Diego, CA); Sihong Chen (Vista, CA); Peter Vander Horn (Encinitas, CA); Tommie Lincecum (Carlsbad, CA)
Assignee: LIFE TECHNOLOGIES CORPORATION
C12Q1/686C12N9/1252C12Q1/6869C12Q2521/101C12Y207/07007
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,976,178
App. No.
14/970,818
Granted
May 22, 2018
Kind
B2
Abstract

The present disclosure provides compositions, methods, kits, systems and apparatus that are useful for nucleic acid polymerization. In particular, modified polymerases and biologically active fragments thereof, such as modified Taq polymerases, are provided that allow for improved nucleic acid amplification. In some aspects, the disclosure provides modified polymerases having improved thermostability, accuracy, processivity and/or read length as compared to a reference Taq polymerase. In some aspects, the disclosure relates to modified polymerases or biologically active fragments thereof, useful for amplification methods, and in practically illustrative embodiments, emulsion PCR.

Claims (18)

1. A method for amplifying a nucleic acid, comprising contacting the nucleic acid with a modified polymerase, under suitable conditions for amplifying the nucleic acid, and amplifying the nucleic acid, wherein the modified polymerase consists of the amino acid sequence of SEQ ID NO: 1 having a single amino acid substitution selected from the group consisting of E397V, G418C, E745T, and E805I, wherein the modified polymerase exhibits polymerase activity and exhibits an improvement in thermostability relative to the reference polymerase of SEQ ID NO: 34.

2. A method according to claim 1 , wherein the modified polymerase has a G418C amino acid substitution.

3. The method of claim 1 , wherein the suitable conditions comprise suitable conditions for performing a polymerase chain reaction.

4. The method of claim 1 , wherein the suitable conditions comprise suitable conditions for performing an emulsion polymerase chain reaction.

5. The method of claim 1 , wherein the amplifying is clonally amplifying the nucleic acid in solution or on a solid support.

6. The method of claim 1 , further comprising determining the nucleic acid sequence of at least a portion of the nucleic acid.

7. The method of claim 1 , wherein the modified polymerase has an E805I amino acid substitution.

8. The method of claim 1 , wherein the modified polymerase has an E745T amino acid substitution.

9. A method for amplifying a nucleic acid, comprising contacting the nucleic acid with a modified polymerase, under suitable conditions for amplifying the nucleic acid, and amplifying the nucleic acid, wherein the modified polymerase consists of the amino acid sequence of SEQ ID NO: 1 having an E397V amino acid substitution, wherein the modified polymerase exhibits polymerase activity and exhibits an improvement in thermostability relative to the reference polymerase of SEQ ID NO: 34.

10. The method of claim 9 , wherein the suitable conditions comprise suitable conditions for performing a polymerase chain reaction.

11. The method of claim 9 , wherein the suitable conditions comprise suitable conditions for performing an emulsion polymerase chain reaction.

12. The method of claim 9 , wherein the amplifying is clonally amplifying the nucleic acid in solution or on a solid support.

13. The method of claim 9 , further comprising determining the nucleic acid sequence of at least a portion of the nucleic acid.

14. A method for amplifying a nucleic acid, comprising contacting the nucleic acid with a modified polymerase, under suitable conditions for amplifying the nucleic acid, and amplifying the nucleic acid, wherein the modified polymerase consists of the amino acid sequence of SEQ ID NO: 1 having E397V and E805I amino acid substitutions, wherein the modified polymerase exhibits polymerase activity and exhibits an improvement in thermostability relative to the reference polymerase of SEQ ID NO: 34.

15. The method of claim 14 , wherein the suitable conditions comprise suitable conditions for performing a polymerase chain reaction.

16. The method of claim 14 , wherein the suitable conditions comprise suitable conditions for performing an emulsion polymerase chain reaction.

17. The method of claim 14 , wherein the amplifying is clonally amplifying the nucleic acid in solution or on a solid support.

18. The method of claim 14 , further comprising determining the nucleic acid sequence of at least a portion of the nucleic acid.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2016
From: MAZUR, DANIEL; TOZER, EILEEN; CHEN, SIHONG; VANDER HORN, PETER; LINCECUM, TOMMIE
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 037812/0157 →
Continuity (2)
Provisional Application 62092756 · Dec 16, 2014
Related Publication 20160177373A1 · Jun 23, 2016